CN106822275A - A kind of composition for significantly improving relieving alcoholism and protecting liver activity, its preparation method and application - Google Patents
A kind of composition for significantly improving relieving alcoholism and protecting liver activity, its preparation method and application Download PDFInfo
- Publication number
- CN106822275A CN106822275A CN201710076838.2A CN201710076838A CN106822275A CN 106822275 A CN106822275 A CN 106822275A CN 201710076838 A CN201710076838 A CN 201710076838A CN 106822275 A CN106822275 A CN 106822275A
- Authority
- CN
- China
- Prior art keywords
- parts
- composition
- extract
- royal jelly
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 82
- 210000004185 liver Anatomy 0.000 title claims abstract description 31
- 208000007848 Alcoholism Diseases 0.000 title claims abstract description 23
- 201000007930 alcohol dependence Diseases 0.000 title claims abstract description 21
- 230000000694 effects Effects 0.000 title claims description 28
- 238000002360 preparation method Methods 0.000 title abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 127
- 239000000284 extract Substances 0.000 claims abstract description 88
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 48
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 48
- 210000000582 semen Anatomy 0.000 claims abstract description 44
- 229940109850 royal jelly Drugs 0.000 claims abstract description 43
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims abstract description 42
- 229930003944 flavone Natural products 0.000 claims abstract description 42
- 150000002212 flavone derivatives Chemical class 0.000 claims abstract description 42
- 235000011949 flavones Nutrition 0.000 claims abstract description 42
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims abstract description 42
- 239000003814 drug Substances 0.000 claims abstract description 25
- 235000013305 food Nutrition 0.000 claims abstract description 20
- 238000010992 reflux Methods 0.000 claims abstract description 13
- 239000007962 solid dispersion Substances 0.000 claims abstract description 8
- 235000005911 diet Nutrition 0.000 claims abstract description 6
- 230000037213 diet Effects 0.000 claims abstract description 6
- 239000007787 solid Substances 0.000 claims abstract description 6
- QHBZHVUGQROELI-SOFGYWHQSA-N (E)-10-hydroxydec-2-enoic acid Chemical compound OCCCCCCC\C=C\C(O)=O QHBZHVUGQROELI-SOFGYWHQSA-N 0.000 claims abstract description 5
- QHBZHVUGQROELI-UHFFFAOYSA-N Royal Jelly acid Natural products OCCCCCCCC=CC(O)=O QHBZHVUGQROELI-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000013402 health food Nutrition 0.000 claims abstract description 5
- 235000019441 ethanol Nutrition 0.000 claims description 72
- 238000000605 extraction Methods 0.000 claims description 26
- 239000007788 liquid Substances 0.000 claims description 21
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 20
- 239000003960 organic solvent Substances 0.000 claims description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 7
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 6
- 238000000975 co-precipitation Methods 0.000 claims description 6
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 claims description 6
- 229920003081 Povidone K 30 Polymers 0.000 claims description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 239000000811 xylitol Substances 0.000 claims description 4
- 235000010447 xylitol Nutrition 0.000 claims description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 4
- 229960002675 xylitol Drugs 0.000 claims description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 229960003511 macrogol Drugs 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- -1 sorbierite Chemical compound 0.000 claims description 3
- 239000007902 hard capsule Substances 0.000 claims description 2
- 238000002844 melting Methods 0.000 claims description 2
- 230000008018 melting Effects 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims 2
- 239000012141 concentrate Substances 0.000 claims 1
- 230000006837 decompression Effects 0.000 claims 1
- 241000699666 Mus <mouse, genus> Species 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 12
- 230000004620 sleep latency Effects 0.000 abstract description 11
- 230000007958 sleep Effects 0.000 abstract description 10
- 241000699670 Mus sp. Species 0.000 abstract description 8
- 238000002474 experimental method Methods 0.000 abstract description 6
- 230000037396 body weight Effects 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 3
- 238000011160 research Methods 0.000 abstract description 3
- 238000013270 controlled release Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 33
- 238000012360 testing method Methods 0.000 description 16
- 238000007792 addition Methods 0.000 description 13
- 241000700159 Rattus Species 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- 239000013068 control sample Substances 0.000 description 8
- 230000035622 drinking Effects 0.000 description 8
- 239000000725 suspension Substances 0.000 description 7
- 210000005228 liver tissue Anatomy 0.000 description 6
- 235000014101 wine Nutrition 0.000 description 6
- 206010067125 Liver injury Diseases 0.000 description 5
- 230000001476 alcoholic effect Effects 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 231100000753 hepatic injury Toxicity 0.000 description 5
- 241000256844 Apis mellifera Species 0.000 description 4
- 241001529936 Murinae Species 0.000 description 4
- 241000736235 Polemonium reptans Species 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000005457 optimization Methods 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 235000020097 white wine Nutrition 0.000 description 4
- CTKXFMQHOOWWEB-UHFFFAOYSA-N Ethylene oxide/propylene oxide copolymer Chemical compound CCCOC(C)COCCO CTKXFMQHOOWWEB-UHFFFAOYSA-N 0.000 description 3
- 235000014787 Vitis vinifera Nutrition 0.000 description 3
- 240000006365 Vitis vinifera Species 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 210000003494 hepatocyte Anatomy 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 229940044519 poloxamer 188 Drugs 0.000 description 3
- 229920001993 poloxamer 188 Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000219780 Pueraria Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000007910 chewable tablet Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010003084 Areflexia Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010009208 Cirrhosis alcoholic Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241001486992 Taiwanofungus camphoratus Species 0.000 description 1
- 206010062129 Tongue neoplasm Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000010002 alcoholic liver cirrhosis Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- MJEMIOXXNCZZFK-UHFFFAOYSA-N ethylone Chemical compound CCNC(C)C(=O)C1=CC=C2OCOC2=C1 MJEMIOXXNCZZFK-UHFFFAOYSA-N 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000007887 hard shell capsule Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000006101 laboratory sample Substances 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 238000010630 lipid peroxidation (MDA) assay Methods 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000016273 neuron death Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 201000005443 oral cavity cancer Diseases 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 229940099429 polyoxyl 40 stearate Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000028527 righting reflex Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 201000006134 tongue cancer Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Insects & Arthropods (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The active composition of relieving alcoholism and protecting liver, its preparation method and application are significantly improved the invention provides a kind of.The composition is made up of royal jelly extract, the root of kudzu vine, hoveniae semoveniae semen.Wherein, the root of kudzu vine, hoveniae semoveniae semen are mixed using 80% alcohol heat reflux and extracted, extract obtained general flavone content >=30%;Royal jelly extract is obtained by raw material of royal jelly through extracting, and royal jelly acid content is between 10~50%;The root of kudzu vine, hoveniae semoveniae semen mixed extract and royal jelly extract addition quick-release, controlled-release solid dispersible carrier, composition is obtained using solid dispersion technology.Experiment shows:Composition provided by the present invention can significantly extend mouse because of the Sleep latency caused by ethanol, curtail sleep, significantly reduce concentration of alcohol in rat blood, reduce because of the influence of ethanol induced mice body weight and liver GSH, MDA, TG, ADH.It is significant to relieving alcoholism and protecting liver medicine, health food, feature ordinary food, the exploitation of special diet food research.
Description
Technical field
The present invention relates to a kind of composition for significantly improving relieving alcoholism and protecting liver activity.More particularly to one kind is extracted by royal jelly
Thing, the root of kudzu vine, hoveniae semoveniae semen compounding, mixing extraction, extract and royal jelly are carried out using 80% alcohol heat reflux to the root of kudzu vine, hoveniae semoveniae semen
The composition that extract is prepared using solid dispersion technology.
Background technology
Low alcohol consumption can invigorate blood circulation, dredging collateral, cold dispelling, excessive consumption of alcohol can then produce " alcoholism " (being commonly called as drunk).Medically
Alcoholism is divided into two kinds of acute alcoholism and chronic alcoholism.Wherein, after acute alcoholism refers to excessive consumption of alcohol,
Bring Nausea and vomiting, dizziness, delirious speech, restless, stupor, gatism, respiration inhibition even dead to patient in the short period
Clinical symptoms;Chronic alcoholism refers to that due to long-term excessive consumption of alcohol the ethanol into human body can not be digested absorption, with blood
Into brain, neuronal cell film is destroyed, weaken central nervous system, and by activating inhibiting nerve original and suppressing activity
Neuron causes slow brain activity, neuronal cell death, severe patient to cause alcoholic cirrhosis and some cancers (such as oral cavity
Cancer, tongue cancer, liver cancer).In recent years since, alcohol consumption colony of China is growing day by day, it has also become factors leading to social instability and enjoy pass
Note.At present, the disintoxicating product that market occurs is more based on chemicals, Chinese patent medicine preparation, while relieving the effect of alcohol, can be different degrees of
Liver, renal metabolism is aggravated to bear and produce different degrees of injury.
The root of kudzu vine, hoveniae semoveniae semen are studied first recorded in China as traditional integration of drinking and medicinal herbs medicinal material, its antialcoholism function《Prescriptions worth thousand gold》、《This
Careless detailed outline》Etc. medical science monumental work.Modern pharmacy, pharmacology, pharmacodynamics, clinical medicine are to the root of kudzu vine, the research of hoveniae semoveniae semen antialcoholism action
Document is more, and the product as development of raw materials listing of relieving the effect of alcohol is also of common occurrence.In addition, " root of kudzu vine relieves the effect of alcohol granular tea and its preparation side
Method (Patent publication No:CN105767355A) " disclose a kind of root of kudzu vine to relieve the effect of alcohol granular tea, by 56~71 parts of the root of kudzu vine, small wheat kernel 10
~15 parts, 4~9 parts of hoveniae semoveniae semen, 5~8 parts of mulberries leaf, 1~3 part of flower of kudzuvine, 5~7 parts of Poria cocos composition;" a kind of protect liver, alleviation are after drinking
Uncomfortable solid beverage and preparation method thereof (Patent publication No:CN106261447A) " disclose a kind of protect liver, alleviate after drinking not
Suitable solid beverage, by 20~40 parts of hoveniae semoveniae semen, 20~40 parts of the root of kudzu vine, 15~35 parts of sea-buckthorn, 10~30 parts of Radix Glycyrrhizae, dark plum 30~
90 parts, 1~6 part of composition of rhizoma zingiberis;It is " a kind of that there is chewable tablets of protective effect and preparation method thereof (patent to alcoholic liver injury
Publication No.:CN106038733A) " disclose a kind of chewable tablets to alcoholic liver injury with protective effect, by rheum officinale 15~
30 parts, 9~30 parts of hoveniae semoveniae semen, 3~6 parts of Antrodia camphorata, 15~30 parts of the Radix Astragali, 9~15 parts of root of kudzu vine composition.
Royal jelly is the secretion of the young worker bee pharynx gland of cultivation larva in honeycomb, is supplied with that queen bee will be become
The food of larva, is also the lifelong food of queen bee.Used as traditional medicine-food two-purpose medicinal material, the pharmacological action of modern study confirmation is to change
Kind nutrition, improve immune, auxiliary prevention cardiovascular and cerebrovascular disease, anti-inflammation anti-cancer, anti-ageing wait for a long time.
It is contemplated that with the royal jelly extract of traditional medicine-food two-purpose, the root of kudzu vine, hoveniae semoveniae semen as combination raw materials, by this hair
The technical schemes such as bright specific composition ratio, extraction process, functional component control, solid dispersion are implemented, and prepare efficient relieving alcoholism and protecting liver
Composition, is research and development relieving alcoholism and protecting liver medicine, health food, feature ordinary food, special medicine food, special diet
Food provides combination raw materials or preparation.
The content of the invention:
The first object of the present invention is to provide a kind of composition for significantly improving relieving alcoholism and protecting liver activity and preparation method thereof;
Second purpose is to provide the application of said composition.
The first object of the present invention is realized using following technical proposals:
First, the present invention provides a kind of composition for significantly improving relieving alcoholism and protecting liver activity, and the composition is by parts by weight
10~19 parts of royal jelly extract, the root of kudzu vine of 291~763 parts of parts by weight, the hoveniae semoveniae semen group of 171~763 parts of parts by weight
Into;
Preferably, the composition by 12~18 parts of parts by weight royal jelly extract, 350~650 parts of parts by weight
The root of kudzu vine, 200~500 parts of parts by weight hoveniae semoveniae semen composition;
Further preferably, the composition by 13~17 parts of parts by weight royal jelly extract, parts by weight 40~600
The root of kudzu vine of part, the hoveniae semoveniae semen composition of 250~450 parts of parts by weight;
Most preferably, the composition by 14~16 parts of parts by weight royal jelly extract, 450~550 parts of parts by weight
The root of kudzu vine, 300~400 parts of parts by weight hoveniae semoveniae semen composition.
Secondly, it is raw material that royal jelly extract system of the present invention uses royal jelly, is obtained using prior art extracting.Its
In, royal jelly acid content is 10%~50%;Preferably 20%~40%;More preferably 30%~40%.
Thirdly, the root of kudzu vine of the present invention, hoveniae semoveniae semen system are mixed using 80% alcohol heat reflux and extracted.Specially:By Pueraria lobota
Root, hoveniae semoveniae semen co-grinding soak 12 hours into 20-40 mesh meal, 80% ethanol wet of addition, and addition solid-liquid ratio is 1:10th, it is dense
Spend for 80% alcohol reflux is extracted three times, extract 1.5 hours every time, extract temperature control between 75~80 DEG C, collect extract solution warp
Concentrated under reduced pressure, dry mixed extract.Wherein, general flavone content >=30%.
Finally, royal jelly extract of the present invention, root of kudzu vine hoveniae semoveniae semen mixed extract are mixed, addition absolute ethyl alcohol,
One or more organic solvents dissolving in ethanol, acetone, chloroform.Addition Macrogol 4000, Macrogol 6000, PVP
Anhydrous second is melted or used to one or more in K30, poloxamer-188, xylitol, sorbierite, citric acid as carrier
Royal jelly extract is added to after one or more organic solvents dissolving in alcohol, ethanol, acetone, chloroform to mix with root of kudzu vine hoveniae semoveniae semen
In extract solution, it is sufficiently mixed uniformly, boils off solvent and obtain the co-precipitation solid dispersions that extract is mixed in the carrier,
Through being drying to obtain composition of the present invention.
Preferably, dissolving royal jelly extract and the organic solvent solid-liquid ratio of root of kudzu vine hoveniae semoveniae semen mixed extract are 1:1~
10, preferably 2~8, more preferably 3~6, most preferably 4~5.
Preferably, carrier dissolving is using heating and melting or addition organic solvent dissolving two ways.Organic solvent dissolving side
Formula solid-liquid ratio is 1:1~10, preferably 2~8, more preferably 3~6, most preferably 4~5.
The second object of the present invention is realized using following technical proposals:
First, composition of the present invention, with relieving alcoholism and protecting livers, liver-protecting function/effect, can be applied to medicine, health care food
Product, feature ordinary food, special medicine food, the exploitation of special diet food research.
Secondly, composition of the present invention can be added or common without medicine, health food, feature as needed
Food, special medicine food, the acceptable auxiliary material of special diet food, are further made granule, tablet, hard capsule, drop
The solid orally ingestibles such as ball.
Specific embodiment
Further detailed description is done to the present invention with reference to specific embodiment, it will be appreciated by those skilled in the art that
These embodiments are merely to illustrate the present invention, but embodiments of the present invention not limited to this.
Embodiment 1:It is prepared by the root of kudzu vine, raisin tree seed extract
The root of kudzu vine of the present invention, hoveniae semoveniae semen system mix extraction using 80% alcohol heat reflux.Specific method is as follows:Take Pueraria lobota
Root, each 100g of hoveniae semoveniae semen crude drug, co-grinding cross 40 mesh sieves, addition 80% appropriate amount of ethanol wetting immersion 12 hours, additive
Liquor ratio is 1:10th, concentration be 80% alcohol reflux extract three times, every time extract 1.5 hours, extract temperature control between 75~80 DEG C,
Extract solution is collected through concentrated under reduced pressure, dry mixed extract 19.92g.Using high effective liquid chromatography for measuring general flavone content,
General flavone content is 54.23% in measuring extract.
The screening of alcohol heat reflux technique for extracting mixed condition of the present invention:
The root of kudzu vine, each 50g of hoveniae semoveniae semen crude drug are taken, co-grinding crosses 40 mesh sieves, addition 80% appropriate amount of ethanol wetting immersion 12
Hour, addition solid-liquid ratio is 1:10th, concentration is that 80% alcohol reflux is extracted three times, is extracted 1.5 hours every time, extracts temperature control 75
Between~80 DEG C, extract solution is collected through concentrated under reduced pressure, dry mixed extract.Using high effective liquid chromatography for measuring general flavone
Content.
Hereinafter investigate experiment and above-mentioned flow implementation is pressed using same batch medicine, consumption is with each 50g of crude drug.
A. the influence of concentration of alcohol
Influence in view of concentration of alcohol to general flavone yield, thus use 20%, 30%, 40%, 50%, 60%, 70%,
80%th, 90%, 100% ethanol, 9 levels are carried out concentration of alcohol process optimization and are investigated, (the temperature in the case where other conditions are constant
78 DEG C of degree, extraction time 1.5h, solid-liquid ratio 1:10), with general flavone content (general flavone content in extract medicinal extract) for investigation refers to
Mark, the results are shown in Table 1.
The different ethanol concentration of table 1 influences result of the test to general flavone yield
By the result in table 1, concentration of alcohol makes curve map to general flavone yield, specific as shown in Figure 1.Can be with from Fig. 1
Find out:In the case where other conditions are constant, when concentration of alcohol is less than 50%, general flavone yield has no significant change;Work as second
During determining alcohol >=50%, with the increase of concentration, the yield of general flavone also rises therewith;When concentration of alcohol is more than 90%, can be with
Find out that yield begins to decline.Therefore, optimum extraction concentration of alcohol is 80%.
B. the influence of temperature
Influence in view of Extracting temperature to general flavone yield, with reference to industrialized production security, using 20,30,40,
50th, 60,70,80,90 DEG C of 8 levels are carried out Extracting temperature process optimization and are investigated, and in the case where other conditions are constant, (ethanol is dense
Degree 80%, extraction time 1.5h, solid-liquid ratio 1:10), with general flavone content (general flavone content in extract medicinal extract) for investigation refers to
Mark, the results are shown in Table 2.
The Extracting temperature of table 2 influences result of study to general flavone yield
Temperature in table 2 is made into curve map to general flavone yield, it is specific as shown in Figure 2.As can be seen from Figure 2:At other
In the case that condition is constant, when temperature is less than 30 DEG C, general flavone is not extracted;When temperature is higher than 30 DEG C, with temperature
Increase, the yield of general flavone also rises therewith;When temperature is more than 80 DEG C, it can be seen that yield starts on a declining curve.Cause
This, optimum extraction temperature is 75~80 DEG C.
C. the influence of extraction time
Influence in view of extraction time to general flavone yield, thus use 30,40,50,60,70,80,90,100,110,
120min10 level is carried out extraction time process optimization and is investigated, (concentration of alcohol 80%, temperature in the case where other conditions are constant
78 DEG C of degree, solid-liquid ratio 1:10), as inspection target, 3 be the results are shown in Table with general flavone content (general flavone content in extract medicinal extract).
The extraction time of table 3 influences result of study to general flavone yield
Extraction time in table 3 is made into curve map to general flavone yield, it is specific as shown in Figure 3.As can be seen from Figure 3:
In the case where other conditions are constant, when extraction time 90min is less than, general flavone yield increases with the increase of extraction time
Greatly;When extraction time 90min is more than, there is obvious downward trend with the increase of extraction time in general flavone yield.Therefore,
The optimum extraction time is 90min.
D. the influence of solid-liquid ratio
The influence to general flavone yield and Cost Problems in view of solid-liquid ratio, therefore it is 1 to use solid-liquid ratio:5、1:6、1:7、1:
8、1:9、1:10、1:11、1:12、1:13 amount to 9 levels carries out the investigation of solid-liquid ratio process optimization, in the feelings that other conditions are constant
Under condition (concentration of alcohol 80%, extraction time 1.5h, 78 DEG C of temperature), with general flavone content (general flavone content in extract medicinal extract)
It is inspection target, the results are shown in Table 4.
The solid-liquid ratio of table 4 influences result of study to general flavone yield
Solid-liquid ratio in table 4 is made into column diagram on the influence of general flavone yield, it is specific as shown in Figure 4.As can be seen from Figure 4:
In the case where other conditions are constant, when solid-liquid ratio is less than 1:When 10, the yield of general flavone increases with the increase of quantity of solvent;When
Solid-liquid ratio is more than 1:When 10, the yield of general flavone is not changed significantly, illustrates that now general flavone has been transferred completely, is section
About cost, it is 1 to select optimal solid-liquid ratio:10.
Brief description of the drawings
The concentration of alcohol of Fig. 1 embodiment of the present invention 1 is to general flavone yield influence curve figure
The Extracting temperature of Fig. 2 embodiment of the present invention 1 is to general flavone yield influence curve figure
The extraction time of Fig. 3 embodiment of the present invention 1 is to general flavone yield influence curve figure
Fig. 4 embodiment of the present invention 1 extracts solid-liquid ratio influences column diagram to general flavone yield
Embodiment 2:Royal jelly extract prepares
Directly purchase the royal jelly extract (remarks that royal jelly acid indicates content >=30%:This royal jelly extract is by royal jelly
The royal jelly of acid content >=1.8% is extracted and is obtained), it is 33.48% to use high performance liquid chromatography self-inspection royal jelly acid content, as
The present composition is prepared and used.
Embodiment 3:Composition prepares 1
A. root of kudzu vine 600g, hoveniae semoveniae semen 450g are taken and mixes extraction by the alcohol heat reflux of embodiment 1, obtain extract 105g;Take reality
The royal jelly extract 18g of the preparation of example 2 is applied, 80 mesh sieves is crossed standby.
B. royal jelly extract, root of kudzu vine hoveniae semoveniae semen mixed extract are mixed, adds 10 times of anhydrous alcohol solutions of amount, system
Into mixed liquor.Addition Macrogol 4000, PVP K30, xylitol as carrier, using being added to after 8 times of acetone solutions of amount
In above-mentioned suspension, it is sufficiently mixed uniformly, boils off solvent and obtain the co-precipitation solid dispersions that extract is mixed in the carrier,
Through dry composition 120g.
Embodiment 4:Composition prepares 2
A. root of kudzu vine 550g, hoveniae semoveniae semen 400g are taken and mixes extraction by the alcohol heat reflux of embodiment 1, obtain extract 95g;Take implementation
The royal jelly extract 16g that example 2 prepares, crosses 100 mesh sieves standby.
B. royal jelly extract, root of kudzu vine hoveniae semoveniae semen mixed extract are mixed, adds 8 times of ethanol dissolvings of amount, be made mixed
Suspension.Addition Macrogol 4000, PVP K30, xylitol as carrier, using being added to after 8 times of anhydrous alcohol solutions of amount
In above-mentioned suspension, it is sufficiently mixed uniformly, boils off solvent and obtain the co-precipitation solid dispersions that extract is mixed in the carrier,
Through dry composition 109g.
Embodiment 5:Composition prepares 3
A. root of kudzu vine 450g, hoveniae semoveniae semen 300g are taken and mixes extraction by the alcohol heat reflux of embodiment 1, obtain extract 75g;Take implementation
The royal jelly extract 14g that example 2 prepares, crosses 80 mesh sieves standby.
B. royal jelly extract, root of kudzu vine hoveniae semoveniae semen mixed extract are mixed, adds 6 times of acetone solutions of amount, be made mixed
Suspension.Addition PVP K30, poloxamer-188, sorbierite are added to above-mentioned as carrier after being dissolved using 5 times of chloroforms of amount
In suspension, it is sufficiently mixed uniformly, boils off solvent and obtain the co-precipitation solid dispersions that extract is mixed in the carrier, through dry
It is dry to obtain composition 87g.
Embodiment 6:Composition prepares 4
A. root of kudzu vine 5000g, hoveniae semoveniae semen 3500g are taken and mixes extraction according to the alcohol heat reflux described in embodiment 1, must extracted
Thing 847g;The royal jelly extract 150g that Example 2 prepares, crosses 80 mesh sieves standby.
B. royal jelly extract, root of kudzu vine hoveniae semoveniae semen mixed extract are mixed, adds the chloroform dissolving of 5 times of amounts to be made suspension
Liquid.Macrogol 4000, poloxamer-188, sorbierite, citric acid are added as carrier, after 4 times of acetone solutions of amount
Add in above-mentioned suspension, be sufficiently mixed uniformly, boil off solvent and obtain the co-precipitation solid point that extract is mixed in the carrier
A prose style free from parallelism, through dry composition 977g.
Embodiment 7:Preparation prepares 1
Composition 200g prepared by Example 5, adds appropriate Icing Sugar, dextrin, lactose, mannitol, through granulation, dry
Granule with relieving alcoholism and protecting liver activity.
Embodiment 8:Preparation prepares 2
Composition 200g prepared by Example 5, addition appropriate amount of starch, Icing Sugar, dextrin, PVP, mucialga of arabic gummy, warp
Mixing, granulation, compressing tablet are made the tablet with relieving alcoholism and protecting liver activity.
Embodiment 9:Preparation prepares 3
Composition 200g prepared by Example 5, addition suitable amount of sucrose, lactose, microcrystalline cellulose, silica, talcum
Powder, magnesium stearate, blended, granulation, filling are prepared into the hard shell capsules with relieving alcoholism and protecting liver activity.
Embodiment 10:Preparation prepares 4
Composition 200g prepared by Example 5, add appropriate Macrogol 4000, Macrogol 6000, odium stearate,
Glycerin gelatine, polyoxyl 40 stearate, blended, dissolving, pill are prepared into the dripping pill with relieving alcoholism and protecting liver activity.
In order to further be illustrated to present composition technique effect, the present invention chooses the honeybee that embodiment 2 prepares
Royal jelly extract, general flavone content be 54.0% kudzu root extract, general flavone content be 54.0% raisin tree seed extract, implement
Root of kudzu vine hoveniae semoveniae semen mixed extract (general flavone content is 54.23%) prepared by example 1 compares sample, numbering be 1., 2., 3.,
④;The composition of the preparation of embodiment 5 is chosen as test specimen, 5. numbering is;Choose weight and compare the root of kudzu vine:Hoveniae semoveniae semen:Royal jelly
Extract=2:2:3 composition (the remarks prepared by embodiment 5:Each component of composition and present composition phase
Same but proportion of composing is outside present composition proportion of composing) used as reference sample, 6. numbering is.Carry out ethanol simultaneously to small
The influence of concentration of alcohol change in influence, the rat blood of mouse Sleep latency and the length of one's sleep, mouse liver protective effect examination
Test, it is as a result as follows:
1. the influence experiment of Mice Hepatocytes Injured by Ethanol Sleep latency and the length of one's sleep
Dosage:5. 60kg adult is defined as 2.4g/ days composition of the present invention to sample dosage, and body is converted accordingly
Weight is that 20g mouse are 252mg/kg to sample dosage.According to etc. dosage determine control sample than principle to sample 6., 4. mouse be to sample
Dosage is 252mg/kg.The dosage such as foundation are to sample than principle, the root of kudzu vine, hoveniae semoveniae semen with reference to national regulation, royal jelly extract
Day highest recommended dose determines that 1. control sample is 62mg/kg to sample amount;2. control sample is 252mg/kg to sample amount;Control sample
3. product are 252mg/kg to sample amount.
Testing program and data:Choose healthy Male Kunming strain mice 70,20 ± 2g of body weight.It is normal feed one week after with
Machine is divided into 7 groups, and numbering is 1.~6. group and blank group.Wherein, 1.~6. group give the sample of reference numeral, blank group is not appointed
Manage where.After 30min 1.~6. group and blank group give 60% ethanol (dosage is 0.32ml/20g).Record each group in detail is small
Mouse righting reflex loss and recovery time, Sleep latency and the length of one's sleep are calculated, the results are shown in Table 5.
The Mice Hepatocytes Injured by Ethanol length of one's sleep of table 5 and Sleep latency influence result of the test
Group | Number of animals | Sleep latency (min) | The length of one's sleep (min) |
① | 10 | 11.3±2.3 | 439±17.23 |
② | 10 | 12.6±1.9 | 423±18.32 |
③ | 10 | 11.9±2.4 | 428±17.96 |
④ | 10 | 13.2±2.5 | 418±18.41 |
⑤ | 10 | 17.5±2.8 | 340±17.89 |
⑥ | 10 | 13.5±2.7 | 416±17.86 |
Blank group | 10 | 9.8±0.1 | 480±0.10 |
Table 5 is found out:At the end of experiment, 1.~6. group compared to blank group Sleep latency, the length of one's sleep by different journeys
Degree improves, and 5. group compared to 1., 2., 3., 4., 6. group and blank group Sleep latency, length of one's sleep p < 0.01, with height
Degree significant difference.
Conclusion (of pressure testing):It is royal jelly extract, kudzu root extract, raisin tree seed extract, root of kudzu vine hoveniae semoveniae semen mixed extract, non-
Ratio of the present invention prepares composition has certain improvement ethanol induced mice Sleep latency and with dormancy time function, but difference is not
Significantly.5. composition of the present invention significantly extends ethanol induced mice Sleep latency, the pharmacological activity for curtailing sleep.
2. on concentration of alcohol change influence experiment in rat blood
Test article:1.~6. number sample, white wine (52 ° of Red Star strong, colourless liquor distilled from sorghum white wine of Beijing Red Star winery manufacture), body
Weigh 200 ± 20g health male rats.
Give sample dosage:5. 60kg adult is defined as 2.4g/ days composition of the present invention to sample dosage, and body is converted accordingly
Weight is that 200g rats are 216mg/kg to sample dosage.According to etc. dosage to sample than principle determine control sample 6., 4. give sample agent
It is 216mg/kg to measure.The dosage such as foundation are to sample than principle, the root of kudzu vine, hoveniae semoveniae semen, royal jelly extract day with reference to national regulation
Highest recommended dose determines that 1. control sample is 54mg/kg to sample amount;2. control sample is 216mg/kg to sample amount;Control sample
3. it is 216mg/kg to sample amount.
Testing program 1:Concentration of alcohol activity confirms in composition reduction rat blood of the present invention
Choose healthy male rat 30, it is normal feed one week after wine group after point blank control group, first medicine, first after drinking at random
Medicine group, every group each 10.Fasting 12h before experiment, to sample, (blank control group gives white wine to gavage, first medicine group is filled after drinking on request
Wine is given after wine group administration 30min after administration, first medicine after 30min after drinking, three groups are 0.015ml/g body weight to vina amount).Respectively
1h, 2h, 3h, 4h take blood from orbital venous plexus after before to sample and to sample, determine concentration of alcohol (remarks:Concentration of alcohol is using beautiful
The dry chemical automatic clinical chemistry analyzers of Kodak of state VTTROS 250 are determined), the results are shown in Table 6, table 7.
Each time period concentration of alcohol (unit mol/L) of each group of table 6
7 liang of test groups concentration of alcohol (unit mol/L) of table
Time (h) | Wine group after first medicine | First medicine group after drinking | P |
Before sample | 2.0±0 | 2.0±0 | |
1 | 25.7±15.4 | 47.5±17.0 | < 0.01 |
2 | 43.4±15.2 | 41.3±15.9 | |
3 | 42.0±16.0 | 44.4±16.2 | |
4 | 31.0±16.5 | 37.6±16.9 | < 0.05 |
Conclusion (of pressure testing):For compared to blank control group, either wine or first medicine, of the present invention group after drinking after first medicine
Compound is respectively provided with significantly reduces concentration of alcohol effect in rat blood.And concentration of alcohol is lived during wine is to reducing rat blood after first medicine
Property is stronger.
Testing program 2:Concentration of alcohol expression activitiy in present composition reduction rat blood
Choose healthy male rat 70, it is normal feed one week after be randomly divided into 7 groups, numbering is 1.~6. group and blank
Group, every group each 10.Fasting 12h, 1.~6. organize gavage respectively and give corresponding test specimen, 1.~6. group and sky after 30min
White group gives white wine by 0.015ml/g body weight gavages.Terminate rear 1h, 2h, 3h, 4h before to sample, to sample simultaneously from eye socket
Veniplex takes blood, determines concentration of alcohol, the results are shown in Table 8.
Table 8 each group different time sections concentration of alcohol (unit mol/L) measurement result
Conclusion (of pressure testing):For blank group, sample 1.~6. group make by certain rat blood concentration of alcohol that reduces
With, but 1., 2., 3., 4., 6. sample difference is not obvious.And sample 5. (composition of the present invention) compared to 1., 2., 3.,
4., 6. for there is pole significant difference (P < 0.01), showing that 5. sample has significantly reduces concentration of alcohol in rat blood and makees
With.
3. the protective effect of pair alcoholic liver injury
Laboratory sample and equipment:Sample 1.~6., electronic balance, UV752N ultraviolet-uisible spectrophotometers, Alpha-D2
Freeze dryer.
Dosage:Tested with reference to Mice Hepatocytes Injured by Ethanol Sleep latency and the influence of the length of one's sleep.
Testing program:Healthy Kunming kind female mice 80, body weight (20 ± 2) g, under same temperature, humidity freely
Feed, water inlet feed one week after, be randomly divided into blank, model comparison, 1.~6. test group amount to 8 groups.Wherein, blank pair
According to group and model group it is daily give 0.9% physiological saline feed, 1.~6. organize daily gavage and give counter sample, continuously feed four
In week, Mouse Weight is weighed per weekend.In after surrounding last dose, disposably giving model group and 1.~6. organize 50% ethanol
12ml/kg BW, blank control group gives 0.9% physiological saline, and fasting can't help water 16h by sacrifice, and solution digs out whole livers
It is dirty, pre- cold saline clean to washing lotion without color after, blot liver surface moisture.Clip 0.1g liver organizations are placed in small beaker
In, prepare 9 times of physiological saline of liver weight, the physiological saline of total amount 2/3 is shifted in beaker, liver is shredded as early as possible,
Enter glass homogenizer, remaining 1/3 rinse after pour into be homogenized together, be made 10% tissue homogenate, in centrifuge with
2000r/min is centrifuged 15min, takes supernatant detection GSH, MDA and TG, the index such as ADH, measurement result be shown in Table 9, table 10, table 11,
Table 12, table 13.
The each group Mouse Weight testing result of table 9
Remarks:During off-test, each group changes of weight no significant difference (P > 0.05).Show that each group mouse growth is normal,
Without because of adverse events and adverse reaction caused by gavage sample.
The each group murine liver tissue GSH assay results of table 10
Group | GSH(mg GSH/mg) |
Blank group | 26.4±1.1 |
Model group | 16.2±0.6 |
① | 17.5±0.8 |
② | 17.8±0.7 |
③ | 17.6±0.9 |
④ | 19.0±0.9 |
⑤ | 24.5±0.8 |
⑥ | 19.1±1.1 |
Table 10 is found out:Blank group significantly reduces (P < 0.01) compared to model group GSH contents, illustrates alcoholic liver injury
Model modeling success.5. compared to 1., 2., 3., 4., 6. group and model control group compare, GSH changes of contents has aobvious test group
Sex differernce (P < 0.01) is write, is positive findings.
MDA assay results in each group murine liver tissue of table 11
Group | MDA(nmol/mg) |
Blank group | 5.3±0.5 |
Model group | 11.5±0.6 |
① | 10.8±0.5 |
② | 10.5±0.7 |
③ | 10.7±0.6 |
④ | 9.5±0.6 |
⑤ | 7.4±0.5 |
⑥ | 9.6±0.4 |
Table 11 is found out:Blank group significantly reduces (P < 0.01) compared to model group GSH contents, illustrates alcoholic liver injury
Model modeling success.5. compared to 1., 2., 3., 4., 6. group and model control group compare, MDA changes of contents has aobvious test group
Sex differernce (P < 0.01) is write, illustrates that composition described in embodiment 5 can reduce lipid peroxidation in the liver that ethanol causes,
Play liver-protective effect.
TG content detection results in each group murine liver tissue of table 12
Group | TG(mmol/L) |
Blank group | 0.6±0.03 |
Model group | 1.3±0.12 |
① | 1.3±0.02 |
② | 1.2±0.03 |
③ | 1.3±0.02 |
④ | 1.1±0.03 |
⑤ | 0.8±0.01 |
⑥ | 1.1±0.02 |
Table 12 is found out:5. compared to 1., 2., 3., 4., 6. group and model control group compare, TG changes of contents has test group
Have significant difference (P < 0.01), illustrate the composition prepared by embodiment 5 can reduce drunk mouse liver tissue in TG contain
Amount, mitigates liver fat and piles up, and plays liver-protective effect.
ADH determination of activity results in each group murine liver tissue of table 13
Group | ADH(U/mg) |
Blank group | 1.1±0.11 |
Model group | 0.9±0.12 |
① | 1.0±0.20 |
② | 1.1±0.30 |
③ | 1.0±0.40 |
④ | 1.2±0.20 |
⑤ | 1.6±0.04 |
⑥ | 1.2±0.03 |
Table 13 is found out:1.~6. group all show necessarily to improve ADH activity in mouse liver tissue relative to model group, 5.
ADH activity improves nearly 60% and 77.8% compared with blank group and model group in group, illustrates the composition of gained in the embodiment of the present invention 5
The activity of ADH in mouse liver can not only be kept, moreover it is possible to excite the activity of ADH, accelerating alcohol metabolism in vivo reduces ethanol
Negative effect to body.
In sum, the relieving alcoholism and protecting liver composition that significantly improves of the present invention has decomposing alcohol, prevention human body alcohol
The effect be poisoned, sobered up.Secondly liver protection function can also effectively be played.
Above content is only specific embodiment of the invention further description made for the present invention, it is impossible to assert
Specific implementation of the invention is confined to these modes.For general technical staff of the technical field of the invention,
On the premise of not departing from present inventive concept, principle, some simple deductions or improvement can also be made, should all be considered as belonging to this hair
Bright protection domain.
Claims (11)
1. it is a kind of to significantly improve the active composition of relieving alcoholism and protecting liver.It is characterized in that:The composition is by parts by weight 10~19
The royal jelly extract of part, the root of kudzu vine of 291~763 parts of parts by weight, the hoveniae semoveniae semen composition of 171~763 parts of parts by weight.
2. composition according to claim 1, it is characterised in that:The composition by 12~18 parts of parts by weight royal jelly
Extract, the root of kudzu vine of 350~650 parts of parts by weight, the hoveniae semoveniae semen composition of 200~500 parts of parts by weight.
3. composition according to claim 1, it is characterised in that:The composition by 13~17 parts of parts by weight royal jelly
Extract, the root of kudzu vine of 400~600 parts of parts by weight, the hoveniae semoveniae semen composition of 250~450 parts of parts by weight.
4. composition according to claim 1, it is characterised in that:The composition by 14~16 parts of parts by weight royal jelly
Extract, the root of kudzu vine of 450~550 parts of parts by weight, the hoveniae semoveniae semen composition of 300~400 parts of parts by weight.
5. the composition according to claim 1-4, it is characterised in that:Royal jelly acid content is 10 in the royal jelly extract
Between~50%, preferably 20%~40%, more preferably 30%~40%.
6. the composition according to claim 1-4, it is characterised in that:The root of kudzu vine, hoveniae semoveniae semen use 80% alcohol heat reflux
Mixing is extracted.Wherein, solid-liquid ratio 1 is extracted:10th, 75~80 DEG C of temperature control, extraction time 1.5h, continuous extraction 3 times, extract solution decompression
Concentrate drying obtains mixed extract.General flavone content >=30%.
7. the composition according to claim 5-6, it is characterised in that:The composition is to be carried royal jelly using organic solvent
Thing and root of kudzu vine hoveniae semoveniae semen mixed extract mixed dissolution are taken, with Macrogol 4000, Macrogol 6000, PVP K30, pool Lip river
One or more in Sha Mu -188, xylitol, sorbierite, citric acid as carrier, melt or using organic solvent dissolving after
Add in royal jelly extract and root of kudzu vine hoveniae semoveniae semen mixed extract, be sufficiently mixed uniformly, boil off solvent and obtain extract in carrier
In the co-precipitation solid dispersions that mix, through being drying to obtain composition of the present invention.
8. composition according to claim 7, it is characterised in that:Mix extraction with root of kudzu vine hoveniae semoveniae semen for royal jelly extract
The organic solvent of thing dissolving is one or more in absolute ethyl alcohol, ethanol, acetone, chloroform, and solid-liquid ratio is 1:1~10, preferably
It is 2~8, more preferably 3~6, most preferably 4~5.
9. composition according to claim 7, it is characterised in that:Carrier is using melting or organic solvent dissolution mechanism.Using
When organic solvent dissolves, the organic solvent for being used is one or more in absolute ethyl alcohol, chloroform, acetone, ethanol, solid-liquid ratio
It is 1:1~10, preferably 2~8, more preferably 3~6, most preferably 4~5.
10. composition according to claims 1 to 9, it is characterised in that:The composition have relieving alcoholism and protecting livers liver-protecting function/
Effect, in can be applied to medicine, health food, feature ordinary food, special medicine food, special diet food.
11. compositions according to claims 1 to 10, it is characterised in that:The composition can be added as needed on or not add
Dosing product, health food, feature ordinary food, special medicine food, the acceptable auxiliary material of special diet food, further make
Into solid orally ingestibles such as granule, tablet, hard capsule, dripping pills.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710076838.2A CN106822275B (en) | 2017-02-13 | 2017-02-13 | Composition capable of remarkably improving hangover-alleviating and liver-protecting activities, preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710076838.2A CN106822275B (en) | 2017-02-13 | 2017-02-13 | Composition capable of remarkably improving hangover-alleviating and liver-protecting activities, preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106822275A true CN106822275A (en) | 2017-06-13 |
CN106822275B CN106822275B (en) | 2020-06-09 |
Family
ID=59128886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710076838.2A Active CN106822275B (en) | 2017-02-13 | 2017-02-13 | Composition capable of remarkably improving hangover-alleviating and liver-protecting activities, preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106822275B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115736063A (en) * | 2022-11-02 | 2023-03-07 | 安徽中医药大学 | Compound tea drink with effects of dispelling effects of alcohol and protecting liver and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104126796A (en) * | 2014-07-18 | 2014-11-05 | 吴自伟 | Health care food capable of dispelling effects of alcohol |
CN106376927A (en) * | 2016-08-25 | 2017-02-08 | 苏州神元生物科技股份有限公司 | Health care product with auxiliary protective effect on chemical liver injury |
-
2017
- 2017-02-13 CN CN201710076838.2A patent/CN106822275B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104126796A (en) * | 2014-07-18 | 2014-11-05 | 吴自伟 | Health care food capable of dispelling effects of alcohol |
CN106376927A (en) * | 2016-08-25 | 2017-02-08 | 苏州神元生物科技股份有限公司 | Health care product with auxiliary protective effect on chemical liver injury |
Non-Patent Citations (1)
Title |
---|
茹清静: "蜂王浆活性成分与护肝机制研究", 《中西医结合肝病杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115736063A (en) * | 2022-11-02 | 2023-03-07 | 安徽中医药大学 | Compound tea drink with effects of dispelling effects of alcohol and protecting liver and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN106822275B (en) | 2020-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101095745B (en) | Particles for invigorating the spleen and preparation method | |
CN106606529A (en) | Composition with auxiliary blood sugar reduction efficacy, and preparation method and application thereof | |
CN107007813A (en) | A kind of efficient relieving alcoholism and protecting liver composition, its preparation method and application | |
CN1840166A (en) | Modern Chinese medicinal oral liquid of 'Wen Dan Tang' and preparation method thereof | |
CN104224811A (en) | Salvia miltiorrhiza medicine and preparation method thereof | |
CN103550398B (en) | Composition for relieving fatigue as well as preparation method and medical application thereof | |
CN105055855B (en) | With Chinese medicine composition for improving sleep, strengthen immunity effect and its preparation method and application | |
CN101574476B (en) | Medicinal material composition used for lowering lipid and protecting liver auxiliarily | |
CN111494360B (en) | Application of epimedin C in medicine for treating diabetic liver injury | |
CN106822275A (en) | A kind of composition for significantly improving relieving alcoholism and protecting liver activity, its preparation method and application | |
CN102048841B (en) | Lactogenic traditional Chinese medicine composition and preparation method thereof | |
CN101167781A (en) | Orally-administered hypoglycemic sweet potato leaf single prescription traditional Chinese medicine and preparation method thereof | |
CN100358507C (en) | Large specification Liuweidihang dripping pills contg. glutinous rehmannia and five other herb medicines, and its prepn. method | |
CN102048890A (en) | Traditional Chinese medicine composition with galactagogue effect and preparation method thereof | |
CN107913277A (en) | The purposes of the anti-uric acid nephropathy of tanshinone | |
CN103705768B (en) | The compositions of prevention alcoholic liver disease and application thereof | |
CN104127816B (en) | A kind of pharmaceutical composition for treating diabetes and its production and use | |
CN101732466B (en) | Method for controlling quality of Guipi granules | |
CN103263581A (en) | Shuangshen capsule for reducing blood sugar | |
CN109999076A (en) | It is a kind of adjust reverse cholesterol transport Chinese medicine composition and its application | |
CN101991721B (en) | Shiqi expathy traditional Chinese medicine sugar-free granule | |
CN100998784A (en) | Traditional Chinese medicine composition tablet for treating gastrointestinal disease and its preparing method | |
CN1954857A (en) | Traditional Chinese medicinal compound preparation for treating asthma and its preparation method | |
CN1785416A (en) | Medicinal preparation for freating chololithiasis and its preparation method | |
CN101991724B (en) | Shiqi Chinese medicinal soft capsules for influenza |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |